These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 32057682)
1. Islets and pancreatic ductal adenocarcinoma - An opportunity for translational research from the 'Bench to the Bedside'. Barreto SG; Michael MZ; Keating DJ Pancreatology; 2020 Apr; 20(3):385-390. PubMed ID: 32057682 [TBL] [Abstract][Full Text] [Related]
2. The conditional expression of KRAS G12D in mouse pancreas induces disorganization of endocrine islets prior the onset of ductal pre-cancerous lesions. Gout J; Pommier RM; Vincent DF; Ripoche D; Goddard-Léon S; Colombe A; Treilleux I; Valcourt U; Tomasini R; Dufresne M; Bertolino P; Bartholin L Pancreatology; 2013; 13(3):191-5. PubMed ID: 23719586 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic ductal carcinoma: from the bench to the bedside. Pezzilli R JOP; 2006 Sep; 7(5):508-10. PubMed ID: 16998251 [No Abstract] [Full Text] [Related]
4. The role of Langerhans islets in pancreatic ductal adenocarcinoma. Pour PM Front Biosci; 1997 Jun; 2():d271-82. PubMed ID: 9206985 [TBL] [Abstract][Full Text] [Related]
5. Identification of Ppy-lineage cells as a novel origin of pancreatic ductal adenocarcinoma. Pereye OB; Nakagawa Y; Sato T; Fukunaka A; Aoyama S; Nishida Y; Mizutani W; Kobayashi N; Morishita Y; Oyama T; Kawabata-Iwakawa R; Watada H; Mizukami H; Fukuda A; Fujitani Y J Pathol; 2024 Aug; 263(4-5):429-441. PubMed ID: 38837231 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Orth M; Metzger P; Gerum S; Mayerle J; Schneider G; Belka C; Schnurr M; Lauber K Radiat Oncol; 2019 Aug; 14(1):141. PubMed ID: 31395068 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma. Chatterjee D; Katz MH; Rashid A; Estrella JS; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Abbruzzese JL; Fleming JB; Wang H Histopathology; 2013 Dec; 63(6):841-51. PubMed ID: 24111684 [TBL] [Abstract][Full Text] [Related]
8. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. Grützmann R; Lüttges J; Sipos B; Ammerpohl O; Dobrowolski F; Alldinger I; Kersting S; Ockert D; Koch R; Kalthoff H; Schackert HK; Saeger HD; Klöppel G; Pilarsky C Br J Cancer; 2004 Mar; 90(5):1053-8. PubMed ID: 14997207 [TBL] [Abstract][Full Text] [Related]
9. TADG-12 as an early marker in the development of pancreatic ductal adenocarcinoma (PDAC): involvement of insulin containing cells. Amsterdam A; Raanan C; Shpigner L; Shwiqi A; Melzer E; Schreiber L Acta Histochem; 2014 Jun; 116(5):781-7. PubMed ID: 24560937 [TBL] [Abstract][Full Text] [Related]
10. A tale of two pancreases: exocrine pathology and endocrine dysfunction. Rickels MR; Norris AW; Hull RL Diabetologia; 2020 Oct; 63(10):2030-2039. PubMed ID: 32894313 [TBL] [Abstract][Full Text] [Related]
11. Modulation of c-kit expression in pancreatic adenocarcinoma: a novel stem cell marker responsible for the progression of the disease. Amsterdam A; Raanan C; Polin N; Melzer E; Givol D; Schreiber L Acta Histochem; 2014 Jan; 116(1):197-203. PubMed ID: 23978330 [TBL] [Abstract][Full Text] [Related]
12. High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients. Sanlioglu AD; Dirice E; Elpek O; Korcum AF; Ozdogan M; Suleymanlar I; Balci MK; Griffith TS; Sanlioglu S Pancreas; 2009 Mar; 38(2):154-60. PubMed ID: 18981952 [TBL] [Abstract][Full Text] [Related]
13. The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities. Tesfaye AA; Kamgar M; Azmi A; Philip PA Expert Rev Anticancer Ther; 2018 Feb; 18(2):131-148. PubMed ID: 29254387 [TBL] [Abstract][Full Text] [Related]
14. Organoid models for translational pancreatic cancer research. Tiriac H; Plenker D; Baker LA; Tuveson DA Curr Opin Genet Dev; 2019 Feb; 54():7-11. PubMed ID: 30844513 [TBL] [Abstract][Full Text] [Related]
15. [Endocrine component of exocrine pancreatic tumors. Apropos of 2 cases]. Kusielewicz D; Houry S; Sabourin JC; Georges O; Roland J; Huguier M; Bodin F Ann Gastroenterol Hepatol (Paris); 1992; 28(1):12-6. PubMed ID: 1313217 [TBL] [Abstract][Full Text] [Related]